99 related articles for article (PubMed ID: 7913884)
1. [Overexpression of c-erbB-2 proto-oncogene product in chondrosarcomas].
Li N; Shen LH; Zhu QF
Zhonghua Bing Li Xue Za Zhi; 1994 Feb; 23(1):37-9. PubMed ID: 7913884
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of the c-erbB-2 oncogene in sarcomas and small round-cell tumors of childhood. An immunohistochemical investigation.
George E; Niehans GA; Swanson PE; Strickler JG; Singleton TP
Arch Pathol Lab Med; 1992 Oct; 116(10):1033-5. PubMed ID: 1358045
[TBL] [Abstract][Full Text] [Related]
3. [TP53 gene aberrations in chondromatous neoplasms: correlation with immunohistochemical p53 accumulation and MDM2 expression].
Blasenbreu S; Baretton GB; Bender C; Haas CJ; Diebold J; Löhrs U
Verh Dtsch Ges Pathol; 1998; 82():284-9. PubMed ID: 10095448
[TBL] [Abstract][Full Text] [Related]
4. [Proto-oncogene C-erbB-2 and human cancer].
Toyoshima K
Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):309-14. PubMed ID: 1968737
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of PTHrP and Bcl-2 expression characterizes the progression of osteochondroma towards peripheral chondrosarcoma and is a late event in central chondrosarcoma.
Bovée JV; van den Broek LJ; Cleton-Jansen AM; Hogendoorn PC
Lab Invest; 2000 Dec; 80(12):1925-34. PubMed ID: 11140704
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical detection of the c-erbB-2 proto-oncogene product in normal, benign and malignant cartilage tissues.
Wrba F; Gullick WJ; Fertl H; Amann G; Salzer-Kuntschik M
Histopathology; 1989 Jul; 15(1):71-6. PubMed ID: 2670729
[TBL] [Abstract][Full Text] [Related]
7. Cytogenetics as a tool in the histologic subclassification of chondrosarcomas.
Dijkhuizen T; van den Berg E; Molenaar WM; Oosterhuis JW; Dam A; Wiersema J; Schraffordt Koops H; de Jong B
Cancer Genet Cytogenet; 1994 Sep; 76(2):100-5. PubMed ID: 7923056
[TBL] [Abstract][Full Text] [Related]
8. Differentiation and proliferation patterns in human trophoblast revealed by c-erbB-2 oncogene product and EGF-R.
Mühlhauser J; Crescimanno C; Kaufmann P; Höfler H; Zaccheo D; Castellucci M
J Histochem Cytochem; 1993 Feb; 41(2):165-73. PubMed ID: 8093455
[TBL] [Abstract][Full Text] [Related]
9. cDNA expression profiling of chondrosarcomas: Ollier disease resembles solitary tumours and alteration in genes coding for components of energy metabolism occurs with increasing grade.
Rozeman LB; Hameetman L; van Wezel T; Taminiau AH; Cleton-Jansen AM; Hogendoorn PC; Bovée JV
J Pathol; 2005 Sep; 207(1):61-71. PubMed ID: 16007578
[TBL] [Abstract][Full Text] [Related]
10. Expression of c-erbB-2 in human esophageal carcinoma cells: overexpression correlated with gene amplification or with GATA-3 transcription factor expression.
Shiga K; Shiga C; Sasano H; Miyazaki S; Yamamoto T; Yamamoto M; Hayashi N; Nishihira T; Mori S
Anticancer Res; 1993; 13(5A):1293-301. PubMed ID: 7902061
[TBL] [Abstract][Full Text] [Related]
11. What's new in breast cancer? Molecular perspectives of cancer development and the role of the oncogene c-erbB-2 in prognosis and disease.
Dawkins HJ; Robbins PD; Smith KL; Sarna M; Harvey JM; Sterrett GF; Papadimitriou JM
Pathol Res Pract; 1993 Dec; 189(10):1233-52. PubMed ID: 7910395
[TBL] [Abstract][Full Text] [Related]
12. Molecular profiling of human chondrosarcomas for matrix production and cancer markers.
Söderström M; Böhling T; Ekfors T; Nelimarkka L; Aro HT; Vuorio E
Int J Cancer; 2002 Jul; 100(2):144-51. PubMed ID: 12115562
[TBL] [Abstract][Full Text] [Related]
13. Genetic alterations in c-erbB-2 protooncogene as prognostic markers in human primary breast tumors.
Nagai MA; Marques LA; Torloni H; Brentani MM
Oncology; 1993; 50(6):412-7. PubMed ID: 7901824
[TBL] [Abstract][Full Text] [Related]
14. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
[TBL] [Abstract][Full Text] [Related]
15. Evidence by in situ hybridization that c-erbB-2 proto-oncogene expression is a marker of malignancy and is expressed in lung adenocarcinomas.
Pääkkö P; Nuorva K; Kamel D; Soini Y
Am J Respir Cell Mol Biol; 1992 Sep; 7(3):325-34. PubMed ID: 1355655
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and predictive relevance of c-erbB-2 and ras expression in node positive and negative breast cancer.
Giai M; Roagna R; Ponzone R; De Bortoli M; Dati C; Sismondi P
Anticancer Res; 1994; 14(3B):1441-50. PubMed ID: 7915096
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and prognosis of chondrosarcoma of bone.
Rozeman LB; Hogendoorn PC; Bovée JV
Expert Rev Mol Diagn; 2002 Sep; 2(5):461-72. PubMed ID: 12271817
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of immunohistochemical c-erbB-2 proto-oncogene expression and nuclear DNA content in human breast cancer.
Schimmelpenning H; Eriksson ET; Falkmer UG; Rutqvist LE; Johansson H; Fallenius A; Auer GU
Eur J Surg Oncol; 1992 Dec; 18(6):530-7. PubMed ID: 1362164
[TBL] [Abstract][Full Text] [Related]
19. Amplification of the c-erbB-2 gene in gastric carcinoma: correlation with survival.
Tsugawa K; Fushida S; Yonemura Y
Oncology; 1993; 50(6):418-25. PubMed ID: 7901825
[TBL] [Abstract][Full Text] [Related]
20. Repressed expression of the HER-2/c-erbB-2 proto-oncogene by the adenovirus E1a gene products.
Yan DH; Chang LS; Hung MC
Oncogene; 1991 Feb; 6(2):343-5. PubMed ID: 1672040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
